Connection

David Taber to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications David Taber has written about Aged, 80 and over.
David Taber
Connection Strength
0.696
Aged, 80 and over
  1. Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy. JAMA Surg. 2021 07 01; 156(7):639-645.
    View in: PubMed
    Score: 0.097
  2. Clinical Outcomes of Older Kidney Transplant Recipients. Am J Med Sci. 2021 08; 362(2):130-134.
    View in: PubMed
    Score: 0.095
  3. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.074
  4. Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation. J Am Coll Surg. 2017 Apr; 224(4):585-592.
    View in: PubMed
    Score: 0.071
  5. Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients. Clin Transplant. 2015 Mar; 29(3):222-6.
    View in: PubMed
    Score: 0.062
  6. The concept of a composite perioperative quality index in kidney transplantation. J Am Coll Surg. 2014 Apr; 218(4):588-97.
    View in: PubMed
    Score: 0.058
  7. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82.
    View in: PubMed
    Score: 0.054
  8. Music Therapy in Dialysis Access Procedures With Moderate Sedation. Am Surg. 2022 Jan; 88(1):70-73.
    View in: PubMed
    Score: 0.023
  9. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovasc Disord. 2020 10 15; 20(1):449.
    View in: PubMed
    Score: 0.023
  10. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
    View in: PubMed
    Score: 0.023
  11. Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease. BMC Nephrol. 2019 07 03; 20(1):241.
    View in: PubMed
    Score: 0.021
  12. Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality. Pharmacotherapy. 2018 11; 38(11):1086-1094.
    View in: PubMed
    Score: 0.020
  13. Feasibility and Functional Testing for Frailty in Chronic Kidney Disease. Prog Transplant. 2018 09; 28(3):299-300.
    View in: PubMed
    Score: 0.020
  14. Effect of frailty on resource use and cost for Medicare patients. J Comp Eff Res. 2018 08; 7(8):817-825.
    View in: PubMed
    Score: 0.020
  15. Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77. Clin Lung Cancer. 2013 May; 14(3):224-9.
    View in: PubMed
    Score: 0.013
  16. Gefitinib plus celecoxib in chemotherapy-na?ve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group. J Thorac Oncol. 2008 Apr; 3(4):374-9.
    View in: PubMed
    Score: 0.010
  17. Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer. Cancer Chemother Pharmacol. 2005 Oct; 56(4):421-6.
    View in: PubMed
    Score: 0.008
  18. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer. Clin Cancer Res. 1998 Apr; 4(4):929-34.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.